Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Hours Spent Record Keeping May Fuel Physician Burnout

Lisa Rapaport  |  September 13, 2016

(Reuters Health)—For every hour doctors spend treating patients during a typical workday, they devote nearly two more hours to maintaining electronic health records (EHR) and clerical work, a small U.S. study suggests. Time spent in meaningful interactions with patients is a powerful driver of physician career satisfaction, but increased paperwork and time on the computer…

Filed under:Billing/CodingPractice SupportProfessional Topics Tagged with:EHRsElectronic health recordsphysician burnout

Rheumatologist Richard M. Pope, MD, Was Honored at Northwestern University Symposium

Ann-Marie Lindstrom  |  September 8, 2016

When the head of the division steps down, how do you mark that event? The Feinberg School of Medicine, Northwestern University-Chicago hosted a day-long symposium to honor Richard M. Pope, MD, who had been chief of the division for 27 years, according to Harris Perlman, PhD, the new chief of the Division of Rheumatology. Richard…

Filed under:Uncategorized Tagged with:ChicagoFeinberg School of MedicineNorthwestern Universityrheumatologistrheumatologysymposium

Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

Deborah Levenson  |  September 8, 2016

Be careful when prescribing allo­purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels have an increased…

Filed under:ConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:AllopurinolGoutoutcomepatient carerheumatologistriskskin reactionTreatmentUric acid

The ACR’s Workforce Study Group to Release 2015 Survey Results

Joan M. Von Feldt, MD, MSEd, FACR, FACP, & Eric L. Matteson, MD, MPH  |  September 7, 2016

The ACR and its Rheumatology Research Foundation continue to work together to provide support for the rheumatology and patient communities. Both organizations are committed to advancing the field of rheumatology with a dedication to expanding the workforce. With a growing number of patients being diagnosed with a rheumatic disease and living longer with the disease,…

Filed under:President's PerspectiveQuality Assurance/ImprovementWorkforce Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)patient carerheumatologysurvey

The Patient's Choice

When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

Charles Radis, DO  |  September 7, 2016

Outside Exam Room No. 5, the chart rack was empty, so I assumed my new consult was late. Just in case, I looked back over my shoulder as I passed by the partially open door and glimpsed the lower half of a woman holding a three-ringed binder on her lap. I squinted and took a…

Filed under:ConditionsPractice SupportPsoriatic Arthritis Tagged with:ArthritisLyme Diseasepatient carePractice ManagementPsoriatic ArthritisRheumatic Diseaserheumatologist

Tocilizumab Promising for sJIA

Michele B. Kaufman, PharmD, BCGP  |  September 7, 2016

In a clinical trial of pediatric patients, tocilizumab proved safe and effective for treating systemic juvenile idiopathic arthritis…

Filed under:ConditionsDrug UpdatesPediatric Conditions Tagged with:clinical trialsPediatricsJIAsystemic juvenile idiopathic arthritistocilizumab

Prepare Now—Not Later—to Meet New Medicare Reimbursement Requirements

Mary Beth Nierengarten  |  September 1, 2016

Providers are urged to prepare quickly to meet the new Medicare reimbursement requirements mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). “The first measurement year starts Jan. 1, 2017, so providers need to prepare quickly,” emphasizes William F. Harvey, MD, MSc, Government Affairs Committee chair, American College of Rheumatology (ACR). 2…

Filed under:Legislation & AdvocacyPractice SupportProfessional Topics Tagged with:alternative payment models (APMs)APMMACRAMACRA RoadshowMedicare Access and CHIP Reauthorization ActMerit-based incentive payment systemMIPS

Placebo Outperforms Glucosamine/Chondroitin Sulfate for Knee OA

Erin Blakemore  |  August 24, 2016

(Reuters Health)—Glucosamine sulfate and chondroitin sulfate are not more beneficial than placebo treatments for patients with knee osteoarthritis, a recent trial suggests. In a double-blind study, researchers investigated the efficacy of a medicine that delivered both glucosamine and chondroitin sulfate. The 164 participants all had osteoarthritis and moderate to severe knee pain. Half the participants…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis & Rheumatologychondroitin sulfateglucosamine sulfatekneeKnee Osteoarthritis (OA)knee painplacebo

Prior Authorization Reform Achieves Some Success

Ryan Larosa, ACR staff  |  August 17, 2016

In early August, the American Medical Association (AMA) held its annual state advocacy strategy meeting in Chicago. This meeting pulls together all state medical societies and national specialty organizations. Over three days, participants engage in roundtable discussions on issues, solutions and best practices for health policy. Networking opportunities abound. The meetings showcase legislation that has…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:American Medical Association (AMA)electronic prior authorizationprior authorization

Treating Asymptomatic Hyperuricemia Could Lower Risk of Developing Chronic Conditions

Martin Garber, DO  |  August 12, 2016

When uric acid becomes elevated in the human body, a variety of problems can develop, most notably gout—a painful, inflammatory arthritis caused by uric acid crystal deposition in joints. Chronically elevated uric acid can also lead to painful kidney stones. The majority of patients found to have hyperuricemia, however, never go on to develop gout…

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:ArthritisdiabetesGouthypertensionhyperuricemiaResearchrheumatologyriskTreatmentUric acidvascular disease

  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences